Work

Abstract P5-19-08: IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs14-p5-19-08

Authors: David M Goldenberg, Linda T Vahdat, Alexander N Starodub, Aditya Bardia, Ellen Chuang, Rebecca L Moroose, Jennifer R Diamond, Robert M Sharkey, Pius P Maliakal, Steven A Hamburger, Allyson J Ocean

Institutions: Center for Molecular Medicine and Immunology, Weill Cornell Medicine, Indiana University, Massachusetts General Hospital, University of Florida Health, UF Health Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1581978003

Cites:

Cited by: 2

Related to: 10